These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3792439)

  • 1. Influence of physical exercise on the pharmacokinetics of propranolol.
    Arends BG; Böhm RO; van Kemenade JE; Rahn KH; van Baak MA
    Eur J Clin Pharmacol; 1986; 31(3):375-7. PubMed ID: 3792439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans.
    Mooy J; Arends B; van Kemenade J; Boehm R; Rahn KH; van Baak M
    J Cardiovasc Pharmacol; 1986; 8(5):940-2. PubMed ID: 2429094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.
    Bauer LA; Murray K; Horn JR; Opheim K; Olsen J
    Eur J Clin Pharmacol; 1989; 37(3):257-60. PubMed ID: 2612540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J; Wilkinson GR; Wood AJ
    N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cimetidine and ranitidine on steady-state propranolol kinetics and dynamics.
    Reimann IW; Klotz U; Frölich JC
    Clin Pharmacol Ther; 1982 Dec; 32(6):749-57. PubMed ID: 6291839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and intravenous propranolol during exercise.
    Sutton JR; Hughson RL; McDonald R; Powles P; Jones NL; Fitzgerald JD
    Clin Pharmacol Ther; 1977 Jun; 21(6):700-5. PubMed ID: 862308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade.
    Wilson TW; Firor WB; Johnson GE; Holmes GI; Tsianco MC; Huber PB; Davies RO
    Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults.
    Panton LB; Guillen GJ; Williams L; Graves JE; Vivas C; Cediel M; Pollock ML; Garzarella L; Krumerman J; Derendorf H
    J Clin Pharmacol; 1995 Sep; 35(9):885-94. PubMed ID: 8786248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green clearance following single and chronic cimetidine doses.
    MacKichan JJ; Schaal SF; Stine RA; Boudoulas H
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):323-6. PubMed ID: 6739959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
    Thuillez C; Richer C; Duhazé P; Bergougnan L; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 29(4):405-11. PubMed ID: 3912184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise].
    Bortone A; Hess OM; Gaglione A; Locuratolo N; Troito G; Rizzon P; Chiddo A
    Cardiologia; 1989 Aug; 34(8):679-88. PubMed ID: 2605578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of propranolol during pregnancy.
    O'Hare MF; Kinney CD; Murnaghan GA; McDevitt DG
    Eur J Clin Pharmacol; 1984; 27(5):583-7. PubMed ID: 6519163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog.
    Bai SA; Abramson FP
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):333-49. PubMed ID: 6502474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rest and exercise hemodynamic effects of sequential alpha-1-adrenoceptor (trimazosin) and beta-adrenoceptor (propranolol) antagonism in essential hypertension.
    Nelson GI; Silke B; Hussain M; Verma SP; Taylor SH
    Am Heart J; 1984 Jul; 108(1):124-31. PubMed ID: 6731261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.